HOXB13 Antibody
-
中文名稱：HOXB13兔多克隆抗體
-
貨號：CSB-PA175658
-
規(guī)格：￥1100
-
圖片：
-
Gel: 15%SDS-PAGE, Lysate: 40 μg, Lane: PC3 cells, Primary antibody: CSB-PA175658(HOXB13 Antibody) at dilution 1/900, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 10 seconds
-
-
其他：
產(chǎn)品詳情
-
Uniprot No.：
-
基因名：HOXB13
-
別名：Homeo box B13 antibody; Homeobox B13 antibody; Homeobox protein Hox B13 antibody; Homeobox protein Hox-B13 antibody; Homeobox protein HoxB13 antibody; HOX B13 antibody; HOXB 13 antibody; HOXB13 antibody; HXB13_HUMAN antibody; PSGD antibody; PSGD protein antibody
-
宿主：Rabbit
-
反應(yīng)種屬：Human,Mouse
-
免疫原：Fusion protein of Human HOXB13
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：Antigen affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA,WB
-
推薦稀釋比：
Application Recommended Dilution ELISA 1:2000-1:5000 WB 1:500-1:2000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能：Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds preferentially to methylated DNA.
-
基因功能參考文獻(xiàn)：
- These results indicate that risk alleles of HOXB13 and common variant SNPs are important components of inherited prostate cancer risk in the Norwegian population, although these factors appear to contribute little to the malignancy's aggressiveness. PMID: 29181843
- Data show that homeo box B13 protein (HOXB13) single nucleotide polymorphisms (SNPs) missense mutations resulted in changed protein stability. PMID: 28272408
- The expression of HOXB13, IL17BR, and mammaglobin 1 in sentinel lymph nodes predict the outcome of primary breast cancer patients. PMID: 29729704
- These results identify HoxB13 as a pivotal upstream regulator of AR-V7-driven transcriptomes that are often cell context-dependent in CRPC, suggesting that HoxB13 may serve as a therapeutic target for AR-V7-driven prostate tumors. PMID: 29844167
- This study evaluated the linkage evidence that identified recurrent mutation in HOXB13 as a risk factor for prostatic neoplasms. PMID: 28790484
- this study revealed that HOXB9, HOXB13, and HOXD13 were upregulated and may play important roles in laryngeal squamous cell carcinoma (LSCC). Moreover, HOXB9 may serve as a novel marker of poor prognosis and a potential therapeutic target in LSCC patients. PMID: 28808656
- none of the recurrent HOXB13 mutations that were identified in the Dutch population were associated with breast cancer risk, although it may be worthwhile to evaluate p.R217C in a larger study or a population with a higher allele frequency. PMID: 27424772
- our results indicated that the G84E mutation in HOXB13 gene might increase susceptibility to prostate cancer PMID: 27626483
- HOXB13 mutation is associated with prostate tumors. PMID: 28186998
- CCAT1 regulates HOXB13 as a molecular decoy for miR-7, a microRNA that targets both CCAT1 and HOXB13, thus facilitating cell growth and migration in esophageal squamous cell carcinoma PMID: 27956498
- This study presents in silico prediction approaches of the deleterious ns single nucleotide polymorphisms (missense) in the homeobox domain of human HOXB13 gene responsible for hereditary prostate cancer. PMID: 28072499
- This is the first study to investigate the HOXB13 G84E mutation in Danish men. The mutation was detected in 0.49% of controls and in 2.51% of cases, and was associated with 5.12-fold increased relative risk of being diagnosed with prostate cancer. In our RP cohort, HOXB13 mutation carriers were more likely to develop aggressive prostate cancer. PMID: 26779768
- HOXB13 is a useful marker for prostate origin when doubt exists regarding the site of the primary of a metastatic lesion PMID: 26931741
- Tumor-associated macrophage-secreted CXCL8 downregulated the ERalpha expression of endometrial cancer cells via HOXB13, which may be associated with cancer invasion, metastasis and poor prognosis. PMID: 27018308
- Study provides insights suggesting that HOXB13 plays an important role in prostate tumorigenesis and malignant progression via the regulation of both p21 and JNK signaling. PMID: 26781690
- The Breast Cancer Index (BCI) is a continuous risk index model of two previously described biomarkers: molecular grade index (MGI) and HOXB13:IL17BR (H:I) ratio PMID: 26728744
- Studies indicate that the germline homeo box B13 protein (HOXB13) p.Gly84Glu mutation is significantly increased the risk of cancers. PMID: 26517352
- review the functions attributed to HOXB13, by highlighting the most recent findings supporting the hypothesis that HOXB13 might serve as a novel biomarker for the prognosis of prostate cancer PMID: 26709644
- Recent studies have shown that HOXB13 is a strong candidate for familial Prostate cancer gene. PMID: 26841725
- The strongest predictors are the BRCA2 mutations, and the highly penetrant G84E mutation in HOXB13 PMID: 26638190
- We showed for the first time that HOXB13 is a sensitive and specific marker for detection of prostatic origin in distant metastases. PMID: 26590121
- The associations between HOXB13 and prostate, leukemia, and bladder suggest that this gene is important in carcinogenesis. PMID: 26108461
- Hoxb-13 overexpression is correlated with tumor angiogenesis, aberrant expression of EMT-associated markers and aggressive clinicopathological characteristics in pancreatic carcinoma. PMID: 26261579
- The prevalence of somatic HOXB13 mutations in prostate cancer. PMID: 26176944
- Our results show that HOXB13/SLUG and ALX4/SLUG axes are novel pathways that promote EMT and invasion of ovarian cancer cells. PMID: 25944620
- our study highlights HOXB13 as strong and independent prognostic marker in prostate cancer PMID: 25825985
- Data show that transcription factor FOXA1 and homeodomain protein HOXB13 colocalize with androgen receptor (AR) at tumor-specific AR binding sites. PMID: 26457646
- HOXB13 G84E germline mutation is associated with prostate cancer risk. PMID: 25595936
- Increased expression of HOXB13 protein is associated with HPV infection and cervical cancer progression. PMID: 25743797
- P63 and HOXB13 is helpful in resolving the diagnosis. PMID: 26200506
- We then show the value of this approach by using the imputed data to investigate the impact of the HOXB13 G84E mutation on age-specific prostate cancer risk and on risk of fourteen other cancers in the cohort PMID: 25629170
- our results suggest that increased HOXB13 expression is associated with tumor angiogenesis and progression in hepatocellular carcinoma PMID: 25031711
- High HOXB13 expression is associated with breast cancer. PMID: 23497539
- The results suggest that the HOXB13-mediated promotion of tumor cell invasion is accomplished mainly through the downregulation of PDEF expression. PMID: 24898171
- While the HOXB13 G84E mutation may be rare, there may be a future role in genetic testing for this mutation after further studies of clinical utility in assessing prostate cancer risk PMID: 24310616
- identified common variants partially correlated with coding variant in the HOXB13 gene (G84E, rs138213197), which has been identified recently as a moderate penetrance prostate cancer susceptibility allele PMID: 24550738
- HOXB13 promotes PCa invasion and metastasis by decreasing intracellular zinc levels, thus stimulating NF-kappaB signals, and acts as a modulator of intracellular zinc levels that promotes the malignant characteristics of PCa PMID: 24096478
- HOXB13 contributes to G1/S and G2/M checkpoint controls in the prostate. PMID: 24325868
- It might enhance cell injury caused by oxidative stress. PMID: 24213000
- No HOXB13 mutation is associated with Ashkenazi Jewish men with prostate cancer. PMID: 23475555
- HOXB13 G84E is prevalent in >1% of the Swedish population and is associated with a 3.5-fold increased risk of prostate cancer PMID: 22841674
- findings suggest that novel molecular pathways may drive prostate cancer in HOXB13 G84E carriers PMID: 24722062
- carriers of the rare G84E variant in HOXB13 were both younger at the time of diagnosis and more likely to have a family history of prostate cancer compared with homozygotes for the wild-type allele. PMID: 24148311
- Our findings provide further evidences that the rare mutation in HOXB13 contributes to both hereditary and sporadic PCa risk. PMID: 24026887
- A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. PMID: 24390282
- Letter/Meta-analysis: HOXB13 germline mutations in European men with prostate neoplasms. PMID: 23518396
- This report is the first to suggest a risk of colorectal cancer associated with mutations in the HOXB13 gene PMID: 23541221
- Our results demonstrate that HOXB13 expression identifies prostatic origin of a carcinoma PMID: 24146108
- High HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERalpha and inducing IL-6 expression. PMID: 23832664
- HOXB13 mutation is associated with prostate cancer. PMID: 23396964
顯示更多
收起更多
-
相關(guān)疾病：Prostate cancer (PC)
-
亞細(xì)胞定位：Nucleus.
-
蛋白家族：Abd-B homeobox family
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
-
-
-
-
-
